2. Kotov S.V., Belomytcev S.V., Guspanov R.I. et al. Yatrogenic urethral strictures in males. Urologija 2018; (4):56–63. Russian (Котов С.В., Беломытцев С.В., Гуспанов Р.И. и др. Ятрогенные стриктуры уретры у мужчин. Урология 2018; (4):56–63).

3. Raheem O.A., Buckley J.C. Adjunctive maneuvers to treat urethral stricture: a review of the world literature. Transl. Androl. Urol. 2014; 3(2):170–178.

4. Nashivochnikova N.A., Krupin V.N., Klochay V.V. A prevention of recurrences of urethral stricture. Medicinskij Vestnik Bashkortostana 2013; 8(2):116–119. Russian (Нашивочникова Н.А., Крупин В.Н., Клочай В.В. Профилактика рецидивов стриктуры уретры. Медицинский Вестник Башкортостана 2013; 8(2):116–119).

5. Wessells H., Angermeier K.W., Elliott S. et al. Male Urethral Stricture: American Urological Association Guideline. J. Urol. 2017; 197(1):182–190.

6. Martov A.G., Ergakov D.V., Salyukov R.V., Fakhredinov G.A. Long-term results of endoscopic treatment of urethral strictures. Urologiia 2007;(5):27–33. Russian (Мартов А.Г., Ергаков Д.В., Салюков Р.В., Фахрединов Г.А. Отдаленные результаты эндоскопического лечения стриктур уретры. Урология 2007;(5):27–33).

7. Martov A.G., Ergakov D.V. The endoscopic treatment of yatrogenic urethral strictures: a prevention of recurrences with the use of Longidaza. Effektivnaya farmakoterapiya. 2014; 41:4–11. Russian (Мартов А.Г., Ергаков Д.В. Эндоскопическое лечение ятрогенных стриктур уретры: профилактика рецидивов с помощью препарата Лонгидаза. Эффективная фармакотерапия. 2014; 41:4–11).

8. Kul’chavenja E.V., Shvecova O.P., Breusov A.A. The rationale for the prescribing and efficiency of the drug Longidaza in patients with chronic prostatitis.. Urologiia 2018; (4):64–71. Russian (Кульчавеня Е.В.,Швецова О.П., Бреусов А.А. Обоснование назначения и эффективность препарата Лонгидаза у больных хроническим простатитом. Урология 2018; (4):64–71).

9. Mundy A.R., Andrich D.E. Urethral strictures. BJU Int. 2011; 107(1):6–26.

10. Sangkum P., Gokce A., Tan R.B.W. et al. Transforming Growth Factor-Beta1 Induced Urethral Fibrosis in a Rat Model. J. Urol. 2015;194(3):820–827.

11. Feng Y.-L., Chen D.-Q., Vaziri N.D. et al. Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis. Med. Res. Rev. 2019; 40:54–78.

12. Cavalcanti A.G., Costa W.S., Baskin L.S. et al. A morphometric analysis of bulbar urethral strictures. BJU Int. 2007;100(2):397–402.

13. Sievert K.-D., Selent-Stier C., Wiedemann J. et al. Introducing a Large Animal Model to Create Urethral Stricture Similar to Human Stricture Disease: A Comparative Experimental Microscopic Study. J. Urol. 2012;187(3):1101–1109.

14. Tolkach Y., Herrmann T., Merseburger A. et al. Development of a clinical algorithm for treating urethral strictures based on a large retrospective single-center cohort. F1000Research 2017; (5):2378.

15. Khokhlov A.N. Deterioration of regeneration with ageing: obligatory or stochastic? Ontogenez. 2013;44(6):434–440. Russian (Хохлов А.Н. Ухудшение регенерации при старении: целесообразность или стохастика? Онтогенез. 2013;44(6):434–440).

16. Lyons M.K., Bonner C.D. Local injections of hydrocortisone for the effective treatment of circumscribed strictures of the urethra. J. Urol. 1957;77(5):741–755.

17. Hebert P.W. The treatment of urethral stricture: transurethral injection of triamcinolone: a preliminary report. J. Urol. 1971;105(3):403–406.

18. Hebert P.W. The treatment of urethral stricture: transurethral injection of triamcinolone. J. Urol. 1972; 108(5):745–747.

19. Mazdak H., Izadpanahi M.H., Ghalamkari A. et al. Internal urethrotomy and intraurethral submucosal injection of triamcinolone in short bulbar urethral strictures. Int. Urol. Nephrol. 2010;42(3):565–568.

20. Tavakkoli Tabassi K., Yarmohamadi A., Mohammadi S. Triamcinolone injection following internal urethrotomy for treatment of urethral stricture. Urol. J. 2011;8(2):132–136.

21. Kravchick S., Lobik L., Peled R., Cytron S. Transrectal ultrasonography-guided injection of long-acting steroids in the treatment of recurrent/resistant anastomotic stenosis after radical prostatectomy. J. Endourol. 2013;27(7):875–879.

22. Hosseini J., Kaviani A., Golshan A.R. Clean Intermittent Catheterization With Triamcinolone Ointment Following Internal Urethrotomy. Urol. J. 2008;5(4):265–268.

23. Kurt O., Gevher F., Yazici C.M. et al. Effect of Mitomycin-C and Triamcinolone on Preventing Urethral Strictures. Int. Braz J Urol 2017;43(5):939–945.

24. Yildirim M.E., Kaynar M., Ozyuvali E. et al. The effectiveness of local steroid injection after internal urethrotomy to avoid recurrence. Arch. Ital. di Urol. Androl. 2016;87(4):295–298.

25. Hao Y.-H., Xing X.-J., Zhao Z.-G. et al. A multimodal therapeutic approach improves the clinical outcome of auricular keloid patients. Int. J. Dermatol. 2019; 58(6):745–749.

26. Syed F., Singh S., Bayat A. Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids. Wound repair Regen. 2013; 21(1):88–102.

27. Ono S., Fujishiro M., Kodashima S. et al. High-dose dexamethasone may prevent esophageal stricture after endoscopic submucosal dissection. Clin. J. Gastroenterol. 2010; 3(3):155–158.

28. Artemov A.V., Alyaev Yu.G., Rapoport L.M., Tsarichenko D.G. Mitomycin in the complex treatment of vesicourethral anastomotic strictures after radical prostatectomy. Urologija 2014;(5):77–80. Russian (Артемов А.В.,Аляев Ю.Г., Рапопорт Л.М., Цариченко Д.Г. Митомицин в комплексном лечении стриктур пузырно-уретрального анастомоза после радикальной простатэктомии. Урология 2014;(5):77–80).

29. Cataneo D.C., Ximenes A.M.G., Cataneo A.J.M. Mitomycin C in the endoscopic treatment of tracheal stenosis: a prospective cohort study. J. Bras. Pneumol. 2018;44(6):486–490.

30. Szabo D., Kovacs D., Endresz V. et al. Antifibrotic effect of mitomycin-C on human vocal cord fibroblasts. Laryngoscope 2019;129(7):E255–E262.

31. El-Asmar K., Amir M., Abdelkader H. et al. Mitomycin C application in resistant caustic esophageal stricture. Ann. Pediatr. Surg. 2011;7(2):49–54.

32. Hollo G. Wound Healing and Glaucoma Surgery: Modulating the Scarring Process with Conventional Antimetabolites and New Molecules. Dev. Ophthalmol. 2017;59:80–89.

33. Mazdak H., Meshki I., Ghassami F. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur. Urol. 2007;51(4):1089–1092.

34. Chang I.Y., Kim J.N., Kim S.-O. et al. Morphological effects of mitomycin C on urothelial responses to experimentally-induced urethral stricture in rats. Int. J. Urol. 2015;22(7):702–709.

35. Hua X., Xu Y., Liu G. et al. An Experimental Model of Anterior Urethral Stricture in Rabbits With Local Injections of Bleomycin. Urology 2018;116:230.e9-230.e15.

36. Uyeturk U., Gucuk A., Firat T. et al. Effect of Mitomycin, Bevacizumab, and 5-Fluorouracil to Inhibit Urethral Fibrosis in a Rabbit Model. J. Endourol. 2014;28(11):1363–1367.

37. Zuo L., Zhang J., Xu X. Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery. J. Ophthalmol. 2018;2018:8965709.

38. Kumar S., Garg N., Singh S.K., Mandal A.K. Efficacy of Optical Internal Urethrotomy and Intralesional Injection of Vatsala-Santosh PGI Tri-Inject (Triamcinolone, Mitomycin C, and Hyaluronidase) in the Treatment of Anterior Urethral Stricture. Adv. Urol. 2014;2014:192710.

39. Kumar S., Kishore L., Sharma A.P. et al. Efficacy of holmium laser urethrotomy and intralesional injection of Santosh PGI tetra-inject (Triamcinolone, Mitomycin C, Hyaluronidase and N-acetyl cysteine) on the outcome of urethral strictures. Cent. Eur. J. Urol. 2015;68(4):462–465.

40. Rhaleb N.E., Peng H., Harding P. et al. Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts. Hypertension 2001;37(3):827–832.

41. Kelly A.P. Medical and surgical therapies for keloids. Dermatol. Ther. 2004;17(2):212–218.

42. Hietanen K.E., Jarvinen T.A., Huhtala H. et al. Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections - a randomized controlled trial. J. Plast. Reconstr. aesthetic Surg. 2019;72(1):4–11.

43. Fu D., Yin J., Huang S. et al. Rapamycin Inhibits the Growth and Collagen Production of Fibroblasts Derived from Human Urethral Scar Tissue. Bio Med Research International 2018;2018:1–9.

44. Chong T., Fu D., Li H. et al. Rapamycin inhibits formation of urethral stricture in rabbits. J. Pharmacol. Exp. Ther. 2011; 338(1):47–52.

45. Sari E., Bakar B., Dincel G.C., Budak Yildiran F.A. Effects of DMSO on a rabbit ear hypertrophic scar model: A controlled randomized experimental study. J. Plast. Reconstr. aesthetic Surg. 2017;70(4):509–517.

46. Shirazi M., Khezri A., Samani S.M. et al. Effect of intraurethral captopril gel on the recurrence of urethral stricture after direct vision internal urethrotomy: Phase II clinical trial. Int. J. Urol. 2007;14(3):203–208.

47. Shirazi M., Soltani M.-R., Jahanabadi Z. et al. Stereological comparison of the effects of pentoxifylline, captopril, simvastatin, and tamoxifen on kidney and bladder structure after partial urethral obstruction in rats. Korean J. Urol. 2014;55(11):756–763.

48. Koshkin V.M., Bogdanec L.I., Nastasheva O.D., Alekseeva E.A. A place of Trental (pentoxifylline) in the treatment of chronic obliterating diseases of arteries of lower extremities and various vascular complications. Mezhdunarodnyj nevrologicheskiy zhurnal 2011;41(3):101–104. Russian (Кошкин В.М., Богданец Л.И., Насташева О.Д., Алексеева Е.А. Место Трентала (пентоксифиллина) в программе лечения хронических облитерирующих заболеваний артерий конечностей и различных сосудистых осложнений. Международный неврологический журнал 2011;41(3):101–104).

49. Sorokin D.A., Sevryukov F.A., Semenychev D.V. et al. The results of the use of hyaluronic acid after endoscopic transurethral procedures for benign prostatic hyperplasia. Medicinskij Vestnik Bashkortostana. 2015;57(3):19–24. Russian (Сорокин Д.А., Севрюков Ф.А., Семенычев Д.В.и др. Результаты применения гиалуроновой кислоты после трансуретральных эндоскопических операций по поводу доброкачественной гиперплазии простаты. Медицинский Вестник Башкортостана. 2015;57(3):19–24).

50. Chung J.H., Kang D.H., Moon H.S. et al. Effects of hyaluronic acid and carboxymethylcellulose on urethral stricture after transurethral resections of the prostate for benign prostatic hyperplasia: a multicenter, single blinded, randomized controlled study. J. Endourol. 2013;27(4):463–469.

51. Chung J.H., Kang D.H., Choi H.Y. et al. The effects of hyaluronic acid and carboxymethylcellulose in preventing recurrence of urethral stricture after endoscopic internal urethrotomy: a multicenter, randomized controlled, single-blinded study. J. Endourol. 2013; 27(6):756–762.

52. Kondratovich L.M. The basics of understanding the formation of adhesions in the abdominal cavity. Intraoperative prophylaxis with drug-loaded anti-adhesion barrier (literature review). Vestnik novyh medicinskih tehnologij 2014;21(3):169–173. Russian (Кондратович Л.М. Основы понимания формирования спаечного процесса в брюшной полости. Интраоперационная профилактика противоспаечными барьерными препаратами (обзор литературы). Вестник новых медицинских технологий 2014;21(3):169–173).

53. Yardimci I., Karakan T., Resorlu B. et al. The effect of intraurethral dexpanthenol on healing and fibrosis in rats with experimentally induced urethral trauma. Urology 2015;85(1):274.e9–13.

54. Moore A.L., DesJardins-Park H.E., Duoto B.A. et al. Doxycycline Reduces Scar Thickness and Improves Collagen Architecture. Ann. Surg. 2018. Doi: 10.1097/SLA.0000000000003172.

55. Liu F., Bayliss G., Zhuang S. Application of nintedanib and other potential anti-fibrotic agents in fibrotic diseases. Clin. Sci. 2019;133(12):1309–1320.

56. Cinar O., Bolat M.S., Erdem S. et al. The effect of an antifibrotic agent, pirfenidone, on penile erectile function in an experimental rat model of ischemic priapism. Int. J. Impot. Res. 2020;32(2):232–238.

57. Yamada T., Kumai Y., Kodama H. et al. Effect of pirfenidone injection on ferret vocal fold scars: A preliminary in vivo study. Laryngoscope 2020;130(3):726–731.

58. Song M.-K., Lee J.-H., Ryoo I.-G. et al. Bardoxolone ameliorates TGF-beta1-associated renal fibrosis through Nrf2/Smad7 elevation. Free Radic. Biol. Med. 2019;138:33–42.

59. Ranti I., Wahyuningsih M.S.H., Wirohadidjojo Y.W. The antifibrotic effect of isolate tagitinin C from tithonia diversifolia (Hemsley) A. Gray on keloid fibroblast cell. Pan Afr. Med. J. 2018;30:264–271.

60. Mudraya I.S., Lopatkin N.A., Ibragimov A.R. et al. The functional state of the detrusor after injection of botulinum toxin. Urologiia. 2008;(3):27–30. Russian (Мудрая И.С., Лопаткин Н.А., Ибрагимов А.Р. и др. Функциональное состояние детрузора мочевого пузыря после инъекционного введения ботулинического токсина. Урология. 2008;(3):27–30).

61. Sahinkanat T., Ozkan K.U., Ciralik H. et al. Botulinum toxin-A to improve urethral wound healing: an experimental study in a rat model. Urology. 2009;73(2):405–409.

62. Wang Y., Wang J., Zhang J. et al. Effectiveness and Safety of Botulinum Toxin Type A Injection for Scar Prevention: A Systematic Review and Meta-analysis. Aesthetic Plast. Surg. 2019;43:1241–1249.

63. Kurt O., Yesildag E., Yazici C.M. et al. Effect of Tadalafil on Prevention of Urethral Stricture After Urethral Injury: An Experimental Study. Urology 2016;91:243e1–243e6.

64. Vasyutin I.A., Lundup A.V., Vinarov A.Z., etc. Reconstruction of urethra using tissue engineering technology. Bulletin of the RAMS. 2017;72(1):17-25. Russian (Васютин И.А., Люндуп А.В., Винаров А.З. и др. Реконструкция уретры с помощью технологий тканевой инженерии. Вестник РАМН 2017; 72(1):17–25).

65. Kotenko K.V., Kyzlasov P.S., Eremin I.I. et al. An innovative minimally invasive method for the treatment of urethral strictures with the use of adipose tissue-derived stem cells. Kletochnaya transpantologiya i tkanevaja inzheneriya. 2013;8(3):35–36. Russian (Котенко К.В., Кызласов П.С., Еремин И.И. и др. Инновационный малоинвазивный способ лечения стриктур уретры с помощью регенеративных клеток жировой ткани. Клеточная транспантология и тканевая инженерия. 2013;8(3):35–36).

66. Sangkum P., Yafi F.A., Kim H. et al. Effect of adipose tissue-derived stem cell injection in a rat model of urethral fibrosis. Can. Urol. Assoc. J. 2016;10(5–6):E175–E180.

67. Castiglione F., Dewulf K., Hakim L. et al. Adipose-derived Stem Cells Counteract Urethral Stricture Formation in Rats. Eur. Urol. 2016;70(6):1032–1041.

68. Wang J., Liao Y., Xia J. et al. Mechanical micronization of lipoaspirates for the treatment of hypertrophic scars. Stem Cell Res. Ther. 2019;10(1):42.

69. Pligina E.G., Soloshenko M.V., Kolyagin D.V. The efficiency of the use of autoplasma for the treatment of children with knee joint cartilage pathology. Rossijskij vestnik detskoj hirurgii, anesteziologii i reanimatologii. 2015;V(3):31–36. Russian (Плигина Е.Г., Солошенко М.В., Колягин Д.В. Эффективность применения аутоплазмы в комплексной терапии детей с патологией хряща коленного сустава. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2015;V(3):31–36).

70. Rezaei M., Badiei R., Badiei R. The effect of platelet-rich plasma injection on post-internal urethrotomy stricture recurrence. World J. Urol. 2019;37:1959–1964.